Organ on a Chip Companies-Corporate Milestones, Value Creation, Cross-border Expansion, Patent Filing and Protection, Leadership Alignment with Trends

Organ on a Chip Forecast and Companies Developments

The global organ on a chip market size is calculated at US$ 159.48 million in 2024, grow to US$ 215.53 million in 2025, and is projected to reach around US$ 3242.34 million by 2034. The market is expanding at a CAGR of 35.15% between 2024 and 2034. The market is estimated to grow significantly due to growing clinical research, and investments in drug development.

Top companies in the organ on a chip include:

Emulate, Inc., MIMETAS B.V., Valo Health, Nortis, Inc., AxoSim,BICO - THE BIO CONVERGENCE COMPANY, CN Bio Innovations Ltd. The Charles Stark Draper Laboratory, Inc., SynVivo, Inc. and AlveoliX AG.

Latest Announcements by Industry Leaders

In November 2024, by establishing its first national guidelines for "organ-on-a-chip technology," China hopes to become the world leader in a promising biotech field. The chips are a new research tool that has the potential to expedite the time it takes for a medicine to get from concept to market and replace animal testing. According to a statement released online by the Institute of Biomedical Devices in Suzhou, this milestone represents a significant advancement for China in the area of organ-on-a-chip standards.

Recent Developments in the Organ on a Chip Market

• In April 2024, $10 million and $5.5 million were invested by Bayland Capital and CN Innovations Holdings Ltd., the company's original stakeholders. The funding will help the company scale and enhance product development in order to address the growing demand for Organ-on-a-Chip (OOC) solutions.
• In May 2023, the Netherlands Research Council (NWO) allocated around 22.7 million euros to seven initiatives aimed at developing cutting-edge scientific infrastructure. At the University of Twente, the Organ-on-Chip Development Center (hDMT INFRA OoCDev), under the direction of Andries van der Meer, will receive more than three million euros.

If you have any questions, please feel free to contact us at sales@towardshealthcare.com